TLPH
Talphera (TLPH)
$90
About Talphera (TLPH)
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Details
Daily high
$0.92
Daily low
$0.88
Price at open
$0.88
52 Week High
$1.57
52 Week Low
$0.38
Market cap
44.0M
Dividend yield
0.00%
Volume
65,549
Avg. volume
130,172
P/E ratio
-2.42
Talphera News
Details
Daily high
$0.92
Daily low
$0.88
Price at open
$0.88
52 Week High
$1.57
52 Week Low
$0.38
Market cap
44.0M
Dividend yield
0.00%
Volume
65,549
Avg. volume
130,172
P/E ratio
-2.42